What You Should Know:
– Cohere Health, a recognized leader in clinical intelligence and prior authorization automation, announced that Humana Inc. (NYSE: HUM) will expand its use of Cohere’s prior authorization platform for diagnostic imaging and sleep services.
– …
Continue Reading
What You Should Know:
Exo® (pronounced “echo”), a medical imaging software and devices company, today announced its FDA-cleared cardiac and lung artificial intelligence (AI) applications are now available on Exo Iris™, Exo’s high-performance handheld ultrasound…
Continue Reading
Syllable Expands Artificial Intelligence Offerings to Health Systems Through the Purchase of Actium Health’s Patient Activation Solution, Thus Furthering its Vision to Advance and Accelerate Patient Access to Care
Syllable Continues on the Path to…
Cambron Carter, Co-founder and Chief Technology Officer at Pearl
The synergy of artificial intelligence (AI) and medical imaging has opened new horizons for healthcare. AI-mediated computer vision has been in use in oncology for more…
Continue Reading
Surgical artificial intelligence (AI) has the potential to improve patient safety and clinical outcomes. To date, training such AI models to identify tissue anatomy requires annotations by expensive and rate-limiting surgical domain experts. Herein,…
Continue Reading
Researchers at the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), have developed an artificial intelligence tool that predicts whether a patient will respond to cancer treatment drugs using individual…
Continue Reading
In an online survey of 100 practicing physicians who work in a large U.S. hospital or health system and use clinical decision support tools, four in five providers – 81% – agreed that generative…
Continue Reading
By Anuja Vaidya
April 19, 2024 – A program that provided automated text messaging with escalation to clinical care, if needed, was not successful in reducing acute care revisits in the 30 days post-hospital discharge, according…
Continue Reading
Accurate prediction of recurrence and progression in non-muscle invasive bladder cancer (NMIBC) is essential to inform management and eligibility for clinical trials. Despite substantial interest in developing artificial intelligence (AI) applications in NMIBC, their…
Continue Reading
By Shania Kennedy
April 18, 2024 – Artificial intelligence (AI)-driven tools can improve the skin cancer diagnostic accuracy of clinicians, nurse practitioners and medical students, according to a study published last week in npj Digital Medicine.
The…
